Real‐World Data on Patients With Acquired Haemophilia A in Japan Undergoing Rehabilitation or With Low Activities of Daily Living Scores: The ORIHIME II Study

Documenti analoghi

• TSUBASA Study: Evaluating Association of Physical Activity and Bleeding Events in People With Haemophilia A Without Factor VIII Inhibitors Receiving Emicizumab
  di: Kagehiro Amano, et al.
  Pubblicazione: (2025)
• Assay Discrepancy in Factor IX Activity in Haemophilia B and the Unique Assay Characteristics of FIX: p.Ala74Pro
  di: Hiroshi Inaba, et al.
  Pubblicazione: (2025)
• Safety, Efficacy and Treatment Patterns of rIX‐FP in Previously Untreated Paediatric Haemophilia B Patients: A Retrospective Chart Review in Japan
  di: Keiji Nogami, et al.
  Pubblicazione: (2025)
• Coagulation Potential in Haemostatic Agents Concomitant With Low Concentration of Emicizumab Under Severe Haemophilia A State
  di: Yuki Kawasaki, et al.
  Pubblicazione: (2025)
• Real‐World Use of Emicizumab in Patients With Acquired Haemophilia A: An Interim Safety Analysis of a Large‐Scale Post‑Marketing Surveillance Study
  di: Midori Shima, et al.
  Pubblicazione: (2026)